$159.16
-0.36-0.23%
al cierre: -
$159.16
0.000.00%
After hour: 4:00 PM EDT
Comments
Loading...
Cardinal Health Actividad de operaciones con información privilegiada
CAHNYSE
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Cardinal Health. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Cardinal Health.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Cardinal Health Inc los iniciados?
Los expertos no han informado de compras ni ventas en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
- El agosto 19, 2025, Mary Scherer, la empresa CHIEF ACCOUNTING OFFICER sold 8.14K acciones por $149.52 cada una.
- El agosto 20, 2025, DEBORAH WEITZMAN, la empresa CEO, PSS SEGMENT sold 21.37K acciones por $150.53 cada una.
- El agosto 19, 2025, Michelle Greene, la empresa CHIEF INFORMATION OFFICER sold 19.99K acciones por $149.41 cada una.
Estadísticas de propiedad de Cardinal Health Inc
Acciones en circulación
237.583M
Acciones en manos de personas con información privilegiada
5.487M
Porcentaje de acciones en manos de personas con información privilegiada
2.31%
Acciones en manos de instituciones
132.005M
Porcentaje de acciones en manos de instituciones
55.6%
Aug 20, 2025 | CEO, PSS SEGMENT | -21.37K | $150.53 | -$3.22M | SELL | -28.57% | 53.43K | Aug 20 | ||
Aug 20, 2025 | CHIEF EXECUTIVE OFFICER | -35.90K | $150.04 | -$5.39M | SELL | -15.22% | 200.00K | Aug 20 | ||
Aug 19, 2025 | CHIEF ACCOUNTING OFFICER | -8.13K | $149.52 | -$1.40M | SELL | -69.58% | 3.56K | Aug 15 - Aug 19 | ||
Aug 19, 2025 | CHIEF INFORMATION OFFICER | -19.99K | $149.41 | -$3.51M | SELL | -57.17% | 14.98K | Aug 15 - Aug 19 | ||
Aug 19, 2025 | CEO, GMPD SEGMENT | -63.43K | $149.41 | -$10.82M | SELL | -70.86% | 26.09K | Aug 15 - Aug 19 | ||
Aug 19, 2025 | CHIEF EXECUTIVE OFFICER | -201.33K | $149.64 | -$36.53M | SELL | -46.05% | 235.90K | Aug 15 - Aug 19 | ||
Aug 19, 2025 | CHIEF LEGAL/COMPLIANCE OFFICER | -56.65K | $149.41 | -$9.86M | SELL | -53.90% | 48.46K | Aug 15 - Aug 19 | ||
Aug 19, 2025 | CHIEF FINANCIAL OFFICER | -71.75K | $149.38 | -$12.41M | SELL | -70.07% | 30.65K | Aug 15 - Aug 19 | ||
Aug 19, 2025 | CHIEF HUMAN RESOURCES OFFICER | -39.92K | $149.44 | -$6.92M | SELL | -71.93% | 15.57K | Aug 15 - Aug 19 | ||
Nov 14, 2024 | CHIEF ACCOUNTING OFFICER | -3.50K | $123.55 | -$432.92K | SELL | -28.59% | 8.75K | Nov 14 | ||
Aug 22, 2024 | CHIEF LEGAL/COMPLIANCE OFFICER | -16.57K | $109.39 | -$1.81M | SELL | -17.91% | 75.97K | Aug 21 | ||
Aug 19, 2024 | CHIEF LEGAL/COMPLIANCE OFFICER | -18.52K | $89.63 | -$3.49M | SELL | -16.68% | 92.54K | Aug 15 - Aug 16 | ||
Aug 19, 2024 | CHIEF FINANCIAL OFFICER | 9.47K | $108.39 | -$520.72K | GRANT | 34.55% | 36.87K | Aug 15 - Aug 19 | ||
Aug 19, 2024 | CHIEF INFORMATION OFFICER | -3.03K | $107.92 | -$846.99K | SELL | -13.60% | 19.24K | Aug 15 - Aug 19 | ||
Aug 19, 2024 | CHIEF EXECUTIVE OFFICER | -63.13K | $108.18 | -$12.04M | SELL | -24.21% | 197.64K | Aug 15 - Aug 19 | ||
Aug 19, 2024 | CHIEF HUMAN RESOURCES OFFICER | -26.57K | $92.83 | -$4.26M | SELL | -49.00% | 27.66K | Aug 15 - Aug 19 | ||
Aug 19, 2024 | CEO, GMPD SEGMENT | -42.64K | $95.98 | -$6.29M | SELL | -51.18% | 40.67K | Aug 15 - Aug 19 | ||
Nov 29, 2023 | CEO, PHARMACEUTICAL SEGMENT | -9.00K | $90.21 | -$1.85M | SELL | -20.36% | 35.20K | Nov 27 | ||
Aug 29, 2023 | CEO, PHARMACEUTICAL SEGMENT | 0.00 | $80.62 | -$123.37K | SELL-OPTIONS | 0.00% | 44.20K | Aug 28 | ||
Aug 21, 2023 | CHIEF ACCOUNTING OFFICER | -9.23K | $80.82 | -$921.71K | SELL | -46.44% | 10.65K | Aug 18 | ||
Aug 17, 2023 | CHIEF LEGAL/COMPLIANCE OFFICER | -45.43K | $84.17 | -$5.37M | SELL | -34.87% | 84.86K | Aug 15 - Aug 17 | ||
Aug 17, 2023 | CEO, MEDICAL SEGMENT | -49.93K | $89.63 | -$5.66M | SELL | -57.20% | 37.35K | Aug 15 - Aug 17 | ||
Aug 17, 2023 | CHIEF INFORMATION OFFICER | 7.16K | $89.16 | -$288.79K | GRANT | 52.43% | 20.81K | Aug 15 - Aug 17 | ||
Aug 17, 2023 | CHIEF HUMAN RESOURCES OFFICER | -28.03K | $80.43 | -$3.42M | SELL | -52.50% | 25.36K | Aug 15 - Aug 17 | ||
Aug 08, 2023 | CHIEF HUMAN RESOURCES OFFICER | 23.29K | $50.35 | $16.31K | BUY | 77.39% | 53.39K | Oct 15 - Aug 07 | ||
Nov 16, 2022 | DIRECTOR | 400.00 | $75.51 | $30.20K | BUY | 13.68% | 3.32K | Nov 14 - Nov 15 | ||
Nov 10, 2022 | DIRECTOR | 2.46K | $79.74 | $11.96K | BUY | 527.47% | 2.92K | Nov 09 - Nov 10 | ||
Nov 09, 2022 | CHIEF HUMAN RESOURCES OFFICER | -20.22K | $78.87 | -$1.55M | SELL | -39.71% | 30.70K | Nov 07 | ||
Nov 09, 2022 | CEO, MEDICAL SEGMENT | -44.35K | $74.34 | -$3.81M | SELL | -47.51% | 49.00K | Nov 07 | ||
Nov 19, 2021 | CHIEF HUMAN RESOURCES OFFICER | -10.00K | $49.17 | -$491.70K | SELL | -21.23% | 37.11K | Nov 18 | ||
Mar 01, 2021 | CHIEF LEGAL/COMPLIANCE OFFICER | -3.50K | $51.53 | -$180.35K | SELL | -21.72% | 12.62K | Feb 26 | ||
Feb 12, 2021 | CHIEF ACCOUNTING OFFICER | -3.29K | $51.98 | -$171.07K | SELL | -35.10% | 6.08K | Feb 11 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.